Completed PHASE4 INTERVENTIONAL 1-arm NCT00909064

The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

Sponsor: Paul Di Cesare,MD

Interventions Fondaparinux Sodium (Arixtra)

Updated 9 times since 2017 Last updated: Apr 5, 2017 Started: Jun 30, 2009 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Total Knee Replacement, this trial is completed. The trial is conducted by Paul Di Cesare,MD and has accumulated 9 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jul 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Feb 2017 — Jul 2017 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Paul Di Cesare,MD

Data source: University of California, Davis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sacramento, United States